Ferroptosis: a potential target for the treatment of atherosclerosis

Acta Biochim Biophys Sin (Shanghai). 2024 Mar 25;56(3):331-344. doi: 10.3724/abbs.2024016.

Abstract

Atherosclerosis (AS), the main contributor to acute cardiovascular events, such as myocardial infarction and ischemic stroke, is characterized by necrotic core formation and plaque instability induced by cell death. The mechanisms of cell death in AS have recently been identified and elucidated. Ferroptosis, a novel iron-dependent form of cell death, has been proven to participate in atherosclerotic progression by increasing endothelial reactive oxygen species (ROS) levels and lipid peroxidation. Furthermore, accumulated intracellular iron activates various signaling pathways or risk factors for AS, such as abnormal lipid metabolism, oxidative stress, and inflammation, which can eventually lead to the disordered function of macrophages, vascular smooth muscle cells, and vascular endothelial cells. However, the molecular pathways through which ferroptosis affects AS development and progression are not entirely understood. This review systematically summarizes the interactions between AS and ferroptosis and provides a feasible approach for inhibiting AS progression from the perspective of ferroptosis.

Keywords: Gpx4; atherosclerosis; ferroptosis; lipid peroxidation.

Publication types

  • Review

MeSH terms

  • Atherosclerosis*
  • Endothelial Cells
  • Ferroptosis*
  • Humans
  • Iron
  • Ischemic Stroke*
  • Lipid Peroxidation
  • Reactive Oxygen Species

Substances

  • Iron
  • Reactive Oxygen Species

Grants and funding

This work was supported by the grants from the National Natural Science Foundation of China (Nos. 82300526 and 82270893) and the Natural Science Foundation of Hubei Province (Nos. 2023 AFB839 and 2022 CFB648).